我武生物：决定终止烟曲霉点刺液研发项目

Core Viewpoint - The company has decided to terminate the research and development project for the Aspergillus niger prick solution due to a comprehensive evaluation of project progress and associated risks, aiming to better allocate R&D resources towards more advantageous projects [1] Group 1: Project Termination - The company will no longer conduct further clinical trials for the Aspergillus niger prick solution [1] - The project was intended for clinical use in skin prick tests to assist in diagnosing type I hypersensitivity diseases caused by Aspergillus sensitization [1] Group 2: Financial Impact - The termination of the project is expected to reduce the company's total profit for 2025 by 4.7684 million yuan [1] - After considering the impact of corporate income tax, the net profit for 2025 will decrease by 3.3379 million yuan [1]